Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02309632 | Pancreatic Cancer Screening of High-Risk Individuals in Arkansas | withdrawn | N/A | 0 | University of ArkansasOTHER | 1 | Jul 29, 2019 | clinicaltrials |
| NCT03778879 | Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B | withdrawn | Phase 1 / Phase 2 | 0 | Alan KatzOTHER | 1 | Jul 19, 2019 | clinicaltrials |
| NCT02205788 |
| Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas |
| withdrawn |
| — |
| 0 |
| Patrick Joseph Loehrer Sr.OTHER |
| 0 |
| Jul 10, 2019 |
| clinicaltrials |
| NCT03697239 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Hitendra PatelOTHER | 1 | Jun 11, 2019 | clinicaltrials |
| NCT03797443 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Piedmont Cancer InstituteOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT03432676 | Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | May 30, 2019 | clinicaltrials |
| NCT03908333 | High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Medical College of WisconsinOTHER | 1 | May 30, 2019 | clinicaltrials |
| NCT03392571 | Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients | withdrawn | Phase 2 | 0 | Pancreatic Cancer Research TeamOTHER | 0 | May 7, 2019 | clinicaltrials |
| NCT02581501 | Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer | withdrawn | Phase 1 | 0 | Stamford HospitalOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT00968604 | C-VISA BikDD: Liposome in Advanced Pancreatic Cancer | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 11, 2019 | clinicaltrials |
| NCT02868632 | Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer | withdrawn | Phase 1 | 0 | NYU Langone HealthOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT01569282 | Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer | withdrawn | N/A | 0 | Göteborg UniversityOTHER | 1 | Mar 22, 2019 | clinicaltrials |
| NCT02570529 | Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy | withdrawn | Phase 4 | 0 | Yonsei UniversityOTHER | 0 | Jan 29, 2019 | clinicaltrials |
| NCT02442739 | Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers | withdrawn | Early Phase 1 | 0 | Cedars-Sinai Medical CenterOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT02967770 | Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic Cancer(PanCAN) | withdrawn | Phase 2 | 0 | Georgetown UniversityOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT00386399 | Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene | withdrawn | Phase 2 | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT01795274 | Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial(PHOENIX-01) | withdrawn | N/A | 0 | University Hospital HeidelbergOTHER | 1 | May 17, 2018 | clinicaltrials |
| NCT02496832 | A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo | withdrawn | N/A | 0 | University Health Network, TorontoOTHER | 0 | Feb 19, 2018 | clinicaltrials |
| NCT03001505 | Registry for Pancreatic Cancer | withdrawn | — | 0 | Duke UniversityOTHER | 1 | Dec 6, 2017 | clinicaltrials |
| NCT02106871 | Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer(PCC) | withdrawn | Phase 1 | 0 | The University of Texas Medical Branch, GalvestonOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT02831179 | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor | withdrawn | Phase 1 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Sep 28, 2017 | clinicaltrials |
| NCT02108782 | Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors | withdrawn | Phase 2 | 0 | Academic and Community Cancer Research UnitedOTHER | 0 | Jul 19, 2017 | clinicaltrials |
| NCT01386502 | CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT02567396 | Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 24, 2017 | clinicaltrials |
| NCT01895790 | Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Johns Hopkins UniversityOTHER | 1 | Mar 6, 2017 | clinicaltrials |
| NCT01434550 | Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer | withdrawn | N/A | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Feb 23, 2017 | clinicaltrials |
| NCT02366858 | Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures | withdrawn | N/A | 0 | AdventHealthOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT02446379 | Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery(CLIO) | withdrawn | — | 0 | Lightpoint Medical LimitedINDUSTRY | 1 | Jan 26, 2017 | clinicaltrials |
| NCT02851381 | Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Oct 7, 2016 | clinicaltrials |
| NCT01045941 | Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma | withdrawn | Phase 2 | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 6, 2016 | clinicaltrials |
| NCT02534246 | Head to Head Comparison of Two Needles EUS Guided FNB | withdrawn | N/A | 0 | Milton S. Hershey Medical CenterOTHER | 1 | Sep 13, 2016 | clinicaltrials |
| NCT00837135 | GI-4000 With Adoptive Transfer in Pancreatic Cancer | withdrawn | Phase 1 | 0 | University of PennsylvaniaOTHER | 0 | Aug 17, 2016 | clinicaltrials |
| NCT01412684 | Distal Pancreatectomy With Partial Splenectomy for Pancreatic Tumors | withdrawn | — | 0 | University of Missouri-ColumbiaOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT01473303 | Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jun 28, 2016 | clinicaltrials |
| NCT01094626 | Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection | withdrawn | N/A | 0 | Elizabeth HechtOTHER | 0 | Jun 10, 2016 | clinicaltrials |
| NCT01784081 | Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer(iPC3) | withdrawn | — | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT01911416 | A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer | withdrawn | N/A | 0 | University of UtahOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT02269683 | Robotic vs. Laparoscopic Distal Pancreatectomy for Pancreatic Cancer(DAVID) | withdrawn | N/A | 0 | Technische Universität DresdenOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02575508 | Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT01814631 | Endoscopic Ultrasound (EUS) Processor Comparison | withdrawn | — | 0 | AdventHealthOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT00580021 | Clinical Outcomes in Hereditary Cancer | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT00227773 | Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Oct 8, 2015 | clinicaltrials |
| NCT01598584 | Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT01954732 | Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery | withdrawn | Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jul 15, 2015 | clinicaltrials |
| NCT01526590 | Contrast Enhanced Endoscopic Ultrasound for Vascular Involvement in Pancreatic Lesions | withdrawn | N/A | 0 | University of VermontOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT00253526 | Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 28, 2015 | clinicaltrials |
| NCT02159248 | Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation | withdrawn | Phase 1 | 0 | Orlando Health, Inc.OTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT01094535 | Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery | withdrawn | N/A | 0 | Columbia UniversityOTHER | 1 | Apr 6, 2015 | clinicaltrials |
| NCT02310971 | Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas | withdrawn | Phase 2 | 0 | Prima BioMed LtdINDUSTRY | 0 | Apr 3, 2015 | clinicaltrials |
| NCT01130701 | A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . .(PMABIIS) | withdrawn | Phase 2 | 0 | University of Massachusetts, WorcesterOTHER | 1 | Mar 17, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Jul 29, 2019source: clinicaltrials